SCHEMBL7662939

SCHEMBL7662939

[O]Cc1ccccc1OCF

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.46
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
DRD1 P21728 8/20 0.43
DRD2 P14416 2/20 0.43
DRD4 P21917 1/20 0.43
DRD5 P21918 1/20 0.43
DRD3 P35462 1/20 0.43
HTR1A P08908 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALB P02768 1/20 0.36
TSPO P30536 1/20 0.36
HPGD P15428 1/20 0.36
ATM Q13315 1/20 0.36
MCL1 Q07820 1/20 0.35
PTPRC P08575 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPRB P23467 1/20 0.35
PTPN6 P29350 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15576954 0.83 L3MBTL1 (0.66) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL7058970 0.82 L3MBTL1 (0.44) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL7682354 0.81 DRD1 (0.50) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL16920291 0.79 DRD1 (0.45) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL15987127 0.78 KDM4E (0.45) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL7053895 0.78 L3MBTL1 (0.41) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL6268621 0.78 L3MBTL1 (0.66) L3MBTL1MAPTNPSR1KDM4EATM
SCHEMBL4090048 0.78 L3MBTL1 (0.42) L3MBTL1MAPTNPSR1DRD1DRD2
SCHEMBL11217443 0.76 CXCL8 (0.60) L3MBTL1MAPTKDM4E
SCHEMBL5090893 0.75 HTR1A (0.67) L3MBTL1MAPTDRD2HTR1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity SIKORSKI JAMES A (US) 2002-11-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, PLTP L3MBTL1 2518/4885MAPT 3071/4885NPSR1 2975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.